{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A bill that would make it easier for Americans to import inexpensive prescription medicines from Canada and Europe is gathering support among some Republicans in the House of Representatives, prompting a furious effort by the pharmaceutical industry to defeat the legislation when it comes up for a vote later this week. The so-called ''reimportation'' bill, which would legalize the importation of drugs already sold in the United States, does not have the support of House Republican leaders. They are bringing it up for consideration as part of a deal they struck with a Missouri Republican, Representative Jo Ann Emerson, to secure Mrs. Emerson's vote in favor of a broad Medicare prescription drug benefit, a measure that is a priority of the White House.", "headline": {"main": "MEASURE TO EASE IMPORTS OF DRUGS IS GAINING IN HOUSE"}, "abstract": "Bill to make it easier for Americans to import less expensive prescription drugs from Canada and Europe gains Republican support in House, prompting furious lobbying by pharmaceutical industry; Republican leaders had promised not to fight 'reimportation' bill as part of deal for Rep Jo Ann Emerson's support for broader Medicare drug benefit, but number of colleagues now send they will vote for measure, noting that sales are going on already, have public support and would save taxpayers money; price comparison table; bill would require FDA to set up system allowing individuals, pharmacies and wholesalers in US to buy FDA-approved drugs from industrialized nations (M)", "print_page": "1", "word_count": 1363, "_id": "4fd243858eb7c8105d7dd655", "snippet": "A bill that would make it easier for Americans to import inexpensive prescription medicines from Canada and Europe is gathering support among some Republicans in the House of Representatives, prompting a furious effort by the pharmaceutical industry...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/07/22/us/measure-to-ease-imports-of-drugs-is-gaining-in-house.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "EMERSON, JO ANN"}, {"name": "glocations", "value": "EUROPE"}, {"name": "glocations", "value": "CANADA"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "PUBLIC OPINION"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By SHERYL GAY STOLBERG and GARDINER HARRIS"}, "document_type": "article", "pub_date": "2003-07-22T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 1, "offset": 0, "time": 24}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}